| Trial ID: | L6534 |
| Source ID: | NCT00738088
|
| Associated Drug: |
Gliclazide
|
| Title: |
Variation in Sulphonylurea Response in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: gliclazide
|
| Outcome Measures: |
Primary: HbA1c reduction, 6 weeks | Secondary: insulin secretory response to glucose and tolbutamide, acute
|
| Sponsor/Collaborators: |
Sponsor: NHS Tayside
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
14
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-06
|
| Completion Date: |
2011-03-03
|
| Results First Posted: |
|
| Last Update Posted: |
2018-05-03
|
| Locations: |
NHS Tayside, Dundee, DD1 9SY, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00738088
|
